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ABSTRACT
Objective: The present study was designed to examine the anti-hypothyroid activity of Withania somnifera (Ashwagandha)’s leaf extract on 6-n-propyl-
2-thio-uracil (PTU) induced hypothyroid rats.
Method: Ethanolic extracts of W. somnifera leaf and Eltroxin were administrated to PTU induced hypothyroid rats. The animals were divided into 
control, PTU treatment, W. somnifera leaf extract treatment, and Eltroxin treatment groups for 60 days. The serum T3 and T4 were estimated, and 
biochemical and hematological parameters of the blood serum were also evaluated.
Results: PTU induction caused a significant decrease (p≤0.001) in T3 and T4 level when compared with the control group. Adverse effects of PTU were 
also observed in blood sugar, cholesterol, alkaline phosphate, protein, albumin, globulin, liver function test, and renal function test parameters. Non-
significant changes in LFT,RFT and Other parameters were observed. W.Somnifera’s leaf extract and Eltroxin treatment group recovered both of the 
thyroid hormone secretion as compare to control.
Keywords: 6-n-Propyl-2-thio-uracil, Hypothyroid, Withania somnifera, Eltroxin.
INTRODUCTION
Hypothyroidism is one of most the common endocrine disorder [1]. 
It is defined as a condition when the level of the thyroid hormones 
decreases below the normal need of the body [2]. The hypothyroidism 
is a complex hormonal dysfunction rather than a single hormonal 
defect [3]. Thyroid hormone is a powerful modulator of cardiac 
function [4]. Hypothyroidism causes the disturbance in body weight 
and appetite [5]. Even during pregnancy time, a significant change in 
thyroid hormone metabolism is observed [6]. Synthetic levothyroxine 
is recommended for hypothyroidism, actually, this drug elevates the 
T3 and T4 level in blood serum so that thyroid gland activity can be 
controlled [7]. Whereas, 6-n-propyl-2-thio-uracil (PTU) is prescribed 
for hyperthyroidism because it can decrease the amount of both 
thyroid hormones secreted by the thyroid gland [8]. Long duration 
usage of the synthetic drug can cure the hypothyroidism, but they 
cause side effects. L-thyroxin can damage the vital organs such as the 
liver and kidney, and it also causes the reduction in body weight and 
an increase in the relative body weight of the kidney [9]. Thus, there 
is a need to develop a drug from plants origin which can work for the 
hypothyroid treatment. Ayurveda suggests that some plant products 
cure hypothyroidism and some investigation on the effects of plant 
products on hypothyroidism is also found. Several bioactive compound 
has been derived from various plants, having anti-thyroidal activity 
and  low toxicity as compare to synthetic drugs, e.g., :Bamboo shoot 
[10]. These plant products can control the basal metabolic rate of the 
body and several cardiovascular diseases like atherosclerosis [11]. 
These extracts have antioxidants and these can affect the metabolism 
of the body too [12]. Withania somnifera can effect on antioxidants 
of animal, and it can increase the serum T3 and T4 significantly. Its 
roots have a compound name withanolides which can cure many 
diseases [13,14]. Roots of the W. somnifera are used in Ayurveda to 
cure hypothyroidism. This study is designed to evaluate the effect 
of W. somnifera leaf extract on hypothyroidism. Therefore, we have 
performed an experiment to examine the effect of W. somnifera leaf 
extract on PTU induced hypothyroid rats. This study is aimed to finding 
out whether W. somnifera leaves can increase Serum T3, T4 level and 
affect the thyroid gland activity positively.
METHODS
Extraction of plant material
W. sominfera plant’s leaves were collected from Jodhpur, Rajasthan 
state, India, and scientific identification was done in the Department of 
Botany, Jai Narai Vyas University, Jodhpur. These leaves were extracted 
with 70% ethanol for 24–36 h by Soxhlet extraction method. Then, 
ethanol was separated under reduced pressure to obtain a blackish 
dark brown crude residue which was dissolved in distilled water and 
orally administrated to the animals.
Model animals
Wistar rats (150–250 g) were purchased from Certified Institute. 
Protocols for animal care, maintenance and experiments were followed 
given by Animal Ethical Committee (IAEC, Reg no.: 1646/GO/Re/12/
CPCSEA). For this experiment, 20 female animals were housed in 
polypropylene cages containing corn-cob bedding and maintained 
at approximately 25–28° F on a 12-h light/dark cycle. For the animal 
adaptability, all rats had been fed for 1 week before the experiment. 
Rats were randomly divided into four groups.
Experimentation
Induction of hypothyroidism
Hypothyroidism was induced in euthyroid rats by administration 
of PTU at the dose of 10mg/kg in drinking water as well as orally for 
30 days.
Dose regime of Eltroxin
Eltroxin was used as a standard drug to cure  hypothyroid that was 
orally administrated at the dose of 0.5 µg/100 g body weight dissolved 
in 50 mL of distilled water.
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Preparation of plant drug
The 70% ethanolic extract (500 mg/kg.b.wt.) was prepared then given 
to the experimentally induced hypothyroid rats.
Experimental design
The experimental period comprised 60 days and the rats were divided 
into the following groups (n=5).
• Group I: Intact control: Rats receiving normal slandered rat pallets 
with saline water.
• Group II: Hypothyroid control: Rats were orally injected PTU for 
hypothyroidism induction for 60 days.
• Group III: W. somnifera leaf extract’s treatment group: PTU treated 
rats received W. somnifera leaf extracts (70% ethanolic extracts) for 
next 30 days on the dose of 500 mg/kg body weight.
• Group IV: Eltroxin treatment group: PTU treated rats received 
Eltroxin at the dose of 0.5 µg/100 g body weight for the next 30 days.
Serum biochemistry
At the end of the experiment, all rats were sacrificed under prolonged 
anesthesia and blood was collected through the direct cardiac puncture. 
Serum was separated and stored at −20°C until analyzed.
Assessment of hormone assays of T3 and T4
Total circulating T3 and T4 in serum were quantitatively determined by 
enzyme-linked immunosorbent assay following the protocols provided 
in the CALBIOTECH kits as routinely followed in our laboratory.
Assessment of liver function test (LFT), renal function test (RFT), 
and other parameters
For the RFT determination in blood serum urea, creatinine, 
and uric acid was estimated by the kit method. Whereas serum 
glutamic oxaloacetic transaminase (SGOT), serum glutamic pyruvic 
transaminase (SGPT), bilirubin direct, bilirubin indirect, and bilirubin 
total were measured for the analysis of LFT. Other parameters such 
as blood sugar, cholesterol, alkaline phosphate, and protein were also 
evaluated by the kit method. All of these tests were analyzed using 
Biochem Analyzer RX-50 and commercial diagnostic kits (Siemens 
Healthcare Diagnostics, USA).
Statistical analysis
The mean and standard deviation was calculated in terms of mean 
±SEM. One-way analysis of variance was used for parametric analysis of 
all groups and calculating the statistical differences between the means 
of the various groups.
Hematology
Blood was collected by direct cardiac puncture at the end of the 
experimental period. Collected blood was stored in EDTA vials at 20°C. 
Hematological assessments of hemoglobin, TRBC, HCT, MCV, MCH, 




Animals treated by PTU demonstrated significant reduction (p≤0.001=c) 
in serum level of T3 and slightly significant reduction (p≤0.05=a,) 
in T4 level as compare to control groups whereas W. somnifera leaf 
extracts treated group’s blood serum have demonstrated no significant 
changes in T3 and T4 level as compared to control groups. Moreover, 
when this Group III was compared to Group II, then it was observed 
that T3 was significantly increase (p≤0.001=g) and T4 had significant 
changes (p≤0.01=f). Eltroxin treatment demonstrated the highly 
significant changes in T3 level as compared to the control group and 
no significant changes as compare to PTU group. Actually, W. somnifera 
and Eltroxin, both groups demonstrated the no significant changes in 
T4 level as compare to control whereas significant changes (p≤0.01=f.) 
were observed when compared to PTU treated rats. In both groups, T4 
exhibited significance (p≤0.01=f) (Figs. 1 and 2).
Morphological studies
Body weight and thyroid weight
No significant changes were observed in body weight in hypothyroid 
and all treatment groups. No significant changes were observed in 
relative body weight of liver, pancreas, and heart, although slight 
reduction in kidney weight was observed in the PTU treatment group 
as compared to control.
Relative body weight of pancreas, heart, kidney, and liver of Groups III 
and IV exhibited slightly differences, or no changes as compared to 
control and PTU treated groups. However, the statistically significant 
difference was observed in the thyroid weight between Group II 
(PTU treated Group) and Group I (control group). Whereas, slightly 
significance or significant changes in relative body weight of thyroid 
was observed in the next two groups (Groups III and IV) as compared to 
control and PTU treated groups (Table 1 and Fig. 3).
RFT
PTU causes some toxicity in kidney which can be observed in RFT 
parameters where significant, slightly significant, and highly significant 
changes were evaluated in urea, creatinine, and uric acid values as 
compared to control group. Whereas W. somnifera leaf extract treatment 
(Group III) and Eltroxin (Group IV) treatment groups had slightly or no 
significantly changes in these parameters as compared to control (Table 2).
LFT
LFT was also affected by PTU in which bilirubin total and bilirubin 
direct were slightly increased whereas SGOT, SGPT, and bilirubin direct 
were significantly increased as compared to the control group. However, 
W. somnifera leaf extract and Eltroxin treatment groups also exhibited 
some changes as compared to the control group (Table 3).
Other parameters
PTU causes some significant changes in blood, sugar, cholesterol, 
alkaline phosphate, albumin, and globulin parameters when compared 
to control group. There is significantly higher blood sugar and 
Fig. 1: Effect of Withania somnifera (Ashwagandha) leaf extract 
on serum T3 in compared to control, 6-n-propyl-2-thio-uracil and 
Eltroxin treatment groups
Fig. 2: Effect of Withania somnifera (Ashwagandha) leaf extract 
on serum T4 in compare to control, 6-n-propyl-2-thio-uracil and 
Eltroxin treatment groups
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cholesterol level observed in blood serum of PTU treated the group 
as compare to control whereas Groups III and IV exhibited no changes 
or slightly changes as compared to control in blood sugar and serum 
cholesterol. There were no significant changes observed in protein 
during experimentation (Table 4).
Hematology profile
All parameter of hematology was calculated when compared with 
control (Table 5).
DISCUSSION
The thyroid gland is a small but most important gland in the mammalian 
body; it plays a pivotal role in overall body function and homeostasis. 
Thyroid gland secret 93% of the thyroxine (T4) which is a metabolically 
inactive hormone and 7% tri-iodothyronine (T3) although later on 
almost all thyroxin is converted in tri-iodothyronine [16]. Thyroid 
hormone exerts a broad range of effects on growth, metabolism, and 
development. The medical manifestations of thyroid hormone excess 
or deficiency are remarkable examples of the innumerable actions of 
the hormone. The primary secretions of the thyroid are thyroxine (T4) 
which are relatively inactive and are converted to the active hormone, 
tri-iodothyronine (T3), by the enzyme thyroxine 5’-deiodinase [17]. 
In the present study, PTU was used to induce hypothyroidism in rats. 
PTU blocks the oxidative iodinationation in the thyroid gland so that 
thyroid hormone-like thyroxine (T4) and tri-iodothyronine (T3) level 
decrease in serum [18], in the present investigation, we have reported 
similar findings. Synthetic drug Eltroxin which is commonly used at 
Table 1: Comparative study of body weight and relative body weight of various organs in intact control, PTU treatment, W. somnifera leaf 
extract treatment and Eltroxin treatment groups
Group name Body weight Relative Body Weight
In g mg/100 g body weight g/100 body 
weight
Initial Final Thyroid Pancreas Heart Kidney Liver
Group I - intact control 123.33±13.33 115±1128 19.93±1.87 316.02±25.4 620.25±60 990±90.16 4.31±0.41
Group II - PTU treated 196.66±18.03 176.66±13.38 73.87±6.42c 106.36±10.95d 555±45.75d 890±8.65a 4.53±0.34d
GroupIII - W. somnifera 
leaf treated
216.66±16.66 146.66±13.66 12.31±1.21b, g 258.54±25.43a, g 426.43±3.954a, e 829.58±52.63b, f 3.606±0.36d, e
GroupIV - Eltroxin 
treated
125±13 116±12.88 16.32±1.65a, g 362.43±21.23d, g 570.13±51.82d, h 966.65±94.42d, e 3.87±0.3d, e
Values expressed as mean±SEM (n=5). Groups II-IV compared with Group I, where ap≤0.05, bp≤0.01, cp≤0.001, and dnon significant. Groups III and IV are compared with 
Group II, where ep≤0.05, fp≤0.01, gp≤0.001, and hnon significant. SEM: Standard error of the mean. PTU: 6-n-propyl-2-thio-uracil, W. somnifera: Withania somnifera
Table 2: Comparative analysis of various parameters of RFT in all groups
Group name Urea (mg/dL) Creatinine (mg/dL) Uric acid (mg/dL)
Group I (control) 36.33±3.63 0.96±0.08 4.16±0.48
Group II (PTU treatment) 47.36±3.27b 1.06±0.1a 15.36±1.38c
Group III (W. somnifera leaf extracts 
treatment)
35.66±3.61d, h 0.8±0.08d, h 4.63±0.3d, h
Group IV (Eltroxin treatment) 36.56±3.56d, h 0.92±0.06a, h 3.35±0.46d, h
Values expressed as mean±SEM (n=5). Groups II-IV compared with Group I, where ap≤0.05, bp≤0.01, cp≤0.001, and dnon significant. Groups III and IV are compared with 
Group II, where ep≤0.05, fp≤0.01, gp≤0.001, and hnon significant. SEM: Standard error of the mean. W. somnifera: Withania somnifera, RFT: Renal function test
Table 3: Comparative study of various parameters of LFT in all groups






SGOT (U/L) SGPT (U/L)
Group I (control) 0.49±0.037 0.13±0.012 0.32±0.02 37.66±3.26 35.1±3.58
Group II (PTU treatment) 0.70±0.05b 0.20±0.018b 0.27±0.025c 148.3±10.15c 312.3±29.18c
Group III (W. somnifera leaf extract 
treatment)
0.86±0.077c, h 0.51±0.027c, g 0.29±0.021c, h 53.7±5.35a, g 41.05±4.66d, g
Group IV - (Eltroxin treatment) 0.59±0.049a, h 0.12±0.011d, f 0.37±0.024c, f 134.55±11.88c, e 73.85±5.86c, g
Values expressed as mean±SEM (n=5). Groups II–IV compared with Group I, where ap≤0.05, bp≤0.01, cp≤0.001 and dnon significant. Groups III and IV are compared with 
Group II, where ep≤0.05, fp≤0.01, gp≤0.001 and hnon significant. SEM: Standard error of the mean. SGPT: Serum glutamic pyruvic transaminase, LFT: Liver function test, 
SGOT: Serum glutamic oxaloacetic transaminase, W. somnifera: Withania somnifera
Table 4: Comparative study of other parameters in blood serum of the rats in all groups












Group I (control) 79±5.77 75.7±6.7 250.73±25.28 6.73±0.46 2.8±0.2 3.9±0.34
Group II (PTU treated) 121.26±11.283b 151±3.46c 121.75±13.7c 5.38±0.43d 2.19±0.21a 2.17±0.15c
Group III-W. somnifera leaf extract 
treatment
84.03±7.96d, e 75.76±4.06d, g 182.91±18.06b, e 5.83±0.44d, h 3.8±0.36a, f 3.56±0.24d, g
Group IV - (Eltroxin treatment) 91.12±8.24d, h 72.86±4.42d, e 349.6±12.41b, g 7.36±0.58d, h 3.08±0.36d, e 4.2±0.34d, g
Values expressed as mean±SEM (n=5). Group II-IV compared with Group I, where ap≤0.05, bp≤0.01, cp≤0.001 and dnon significant. Groups III and IV are compared with 
Group II, where ep≤0.05, fp≤0.01, gp≤0.001, and hnon significant. SEM: Standard error of the mean, W. somnifera: Withania somnifera
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the different dosage to control hypothyroidism in human being shows 
a significant increase of T4 and T3 level. In the present investigation, 
Eltroxin was used as a standard drug which causes significant 
improvement in T3 and T4 level in hypothyroid rats. Similar findings 
have been reported by plant-like W. somnifera and Bauhinia purpurea in 
female mice [19]. This is mainly due to changing the inactive hormone 
to active hormone [20,21]. The green medicine (W. somnifera’s leaf 
extract) can also increase the level of T3 and T4 in the experimental group 
without any side effects. This is mainly due to beneficial effects of plant 
extract on the thyroid gland. The improvement of T3 and T4 suggests 
that plant extract possesses T3 and T4 like compound, which mimics 
like Eltroxin [22,23]. Some plants show thyroid stimulating actions [24] 
and suggested that green medicines positively effect on serum T3 and 
T4. Besides this, they increase the hepatic glucose-phosphate activity 
and hepatic-lipid-peroxidase activity [25]. In the present investigation, 
increase of glucose was reported in blood and abnormal function of 
kidney and liver by PTU treatment. This is mainly due to the adverse 
effect of PTU on the vital organs. In the present investigation when 
the plant extract was given to PTU induced hypothyroid rats, all these 
parameters come to the normal range which shows a beneficial effect 
of W. somnifera leaf extract in controlling hypothyroid without showing 
any toxicity on liver and kidney. These findings reported by a different 
scientist on plant product which shows low toxicity of green medicine 
[26]. The current study indicates that the plant extracts are having no 
toxicity which is reflecting in hematology. All parameters of hematology 
in treatment groups were within the normal range. The current study 
recommends that W. somnifera extract can cure hypothyroidism without 
causing any adversity on the vital organ as well as on hematology.
CONCLUSION
The present finding reveals that W. somnifera leaf extract can control 
the hypothyroidism. It normalize the T3 and T4 level in blood serum. 
Moreover, it does not show any toxicity in any of the LFT and RFT 
parameters and hematology of the rat’s blood.
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